
It has emerged that NICE has awarded its recommendation to Vifor Pharma’s Veltassa (patiromer) for treating hyperkalaemia, a condition classified …

Galenica has announced that it has entered into an agreement to acquire Relypsa in a deal worth $1.53 billion, which …

How did you find your way into your current role? I began my career in the UK as a sales …

